ArticleCellular oncology (Dordrecht, Netherlands)2025

S100A9 promotes resistance to anti-PD-1 immunotherapy in hepatocellular carcinoma by degrading PARP1 and activating the STAT3/PD-L1 pathway.

Xianwei Zhou et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.